Rating
Buy
Price target
$640
Previous
Implied upside
+20%

Mizuho analyst Gregg Moskowitz reiterated on October 28, 2025, an ‘Outperform’ rating and $640 price target on Microsoft.

“This morning, MSFT and OpenAI announced an important agreement reflecting updates to the partnership.

We previously contended that, despite growing investor concern, this relationship continues to be both healthy overall and a significant positive for MSFT.

In our view, today’s announcement clearly supports that.

In the end, while neither party got all that it wanted, we believe this agreement is a winwin.

For MSFT, it critically retains its revenue share for the foreseeable future, along with exclusive IP rights and Azure API exclusivity until Artificial General Intelligence (AGI) is attained, while obtaining a ~27% equity stake and ceding its right of first refusal.

More broadly, we remain confident MSFT’s revenue growth opportunities over the medium-term and beyond are greater than many realize, and we remain very bullish on its tangible AI adoption and monetization levers.

We reiterate our Outperform rating and maintain our PT of $640.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.